Atria Investments
SAGE icon

Atria Investments’s Sage Therapeutics SAGE Stock Holding History

Atria Investments’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,594
Closed -$218K – 720
2020
Q1 		$218K Buy
7,594
+4,739
+166% +$274K 0.02% 513
2019
Q4 		$206K Buy
2,855
+759
+36% +$93.4K 0.01% 1142
2019
Q3 		$294K Buy
2,096
+71
+4% +$11.9K 0.01% 721
2019
Q2 		$331K Sell
2,025
-14
-0.7% -$2.39K 0.01% 712
2019
Q1 		$324K Sell
2,039
-173
-8% -$25.1K 0.01% 670
2018
Q4 		$212K Buy
2,212
+677
+44% +$77.5K 0.01% 797
2018
Q3 		$217K Buy
1,535
+141
+10% +$21.8K 0.01% 898
2018
Q2 		$218K Buy
+1,394
New +$219K 0.01% 871

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Atria Investments's SAGE Position: Q2 2020 in Review

Atria Investments sold out of Sage Therapeutics (SAGE) in Q2 2020, closing a stake of 7,594 shares — an estimated $218K sold.

Atria Investments first reported a position in SAGE in Q2 2018 and held it in 8 quarters. The position peaked at $331K in Q2 2019. 217 funds tracked by Wall St. Rank hold SAGE as of Q2 2020.

  • Atria Investments reported no remaining Sage Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Atria Investments sold 7,594 Sage Therapeutics shares in Q2 2020, an estimated $218K.
  • Atria Investments first reported a position in Sage Therapeutics in Q2 2018 and held it in 8 quarters.
  • Atria Investments's Sage Therapeutics position peaked at $331K in Q2 2019.
  • 217 funds tracked by Wall St. Rank held Sage Therapeutics as of Q2 2020.

Based on Atria Investments's 13F filing for Q2 2020, filed 13 Aug 2020.